We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 21-40 of 10,000 results
  1. Re-administration of platinum-based chemotherapy for recurrent endometrial cancer: an ancillary analysis of the SGSG-012/GOTIC-004/Intergroup study

    Background

    We previously demonstrated the applicability of the concept of “platinum sensitivity” in recurrent endometrial cancer. Although immune...

    Shoji Nagao, Shin Nishio, ... Hisashi Masuyama in International Journal of Clinical Oncology
    Article Open access 13 July 2024
  2. Ferroptosis – a potential feature underlying neratinib-induced colonic epithelial injury

    Purpose

    Neratinib, a small-molecule tyrosine kinase inhibitor (TKI) that irreversibly binds to human epidermal growth factor receptors 1, 2 and 4...

    Triet P. M. Nguyen, Susan L. Woods, ... Joanne M. Bowen in Cancer Chemotherapy and Pharmacology
    Article Open access 13 July 2024
  3. LncRNA ZFAS1 regulates ATIC transcription and promotes the proliferation and migration of hepatocellular carcinoma through the PI3K/AKT signaling pathway

    Purpose

    Long noncoding RNAs (lncRNAs) exert a significant influence on various cancer-related processes through their intricate interactions with...

    Baoyang Luo, Lin Zhuang, ... Haisheng Fang in Journal of Cancer Research and Clinical Oncology
    Article Open access 13 July 2024
  4. High-risk pathogenic germline variants in blood relatives of BRCA1/2 negative probands

    Background

    Tailored, preventive cancer care requires the identification of pathogenic germline variants (PGVs) among potentially at-risk blood...

    Reiko Yoshida, Tomoko Kaneyasu, ... Seigo Nakamura in Breast Cancer
    Article Open access 13 July 2024
  5. Synergistic induction of mitotic pyroptosis and tumor remission by inhibiting proteasome and WEE family kinases

    Mitotic catastrophe (MC), which occurs under dysregulated mitosis, represents a fascinating tactic to specifically eradicate tumor cells. Whether...

    Zhan-Li Chen, Chen **e, ... Shi-Mei Zhuang in Signal Transduction and Targeted Therapy
    Article Open access 12 July 2024
  6. Hepatocellular Carcinoma in Asia: Physician and Patient Perspectives on Surveillance, Diagnosis, and Treatment

    Purpose

    In several Asian countries, hepatocellular carcinoma (HCC) is a leading cause of cancer deaths. HCC risk factors in Asia differ from those...

    Rosmawati Mohamed, Wendy Wang, ... Chee-Kiat Tan in Journal of Gastrointestinal Cancer
    Article Open access 12 July 2024
  7. An analysis of the role of GAB2 in pan-cancer from a multidimensional perspective

    Background

    To explore the role of GAB2 in pan-cancer based on bioinformatics analysis.

    Methods

    Based on TCGA and GTEx databases, we used TIMER2.0...

    Yi Yin, Yong Li, ... Rui Ji in Discover Oncology
    Article Open access 12 July 2024
  8. The diagnostic and prognostic value of tartrate-resistant acid phosphatase isoform 5b for giant cell tumor of bone

    Background

    Serum level of tartrate-resistant acid phosphatase 5b (TRACP5b) is an excellent serum marker of bone resorption. In patients with giant...

    Yu Toda, Koichi Ogura, ... Akira Kawai in International Journal of Clinical Oncology
    Article 12 July 2024
  9. Comparative analysis of reduced toxicity conditioning regimens between fludarabine plus melphalan and fludarabine plus busulfex in adult patients with acute lymphoblastic leukemia

    Reduced-toxicity conditioning (RTC) regimens aim to mitigate regimen-related toxicity while maintaining anti-leukemic efficacy in allogeneic...

    Jaehyun Ahn, Jae-Ho Yoon, ... Seok Lee in Bone Marrow Transplantation
    Article 12 July 2024
  10. MICAL1 promotes the proliferation in acute myeloid leukemia and is associated with clinical prognosis and immune infiltration

    Acute myeloid leukemia (AML) is one of the most common hematopoietic malignancies that has a poor prognosis and a high rate of relapse. Dysregulated...

    Yinsen Song, Zhenzhen Yang, ... Bojun Zhang in Discover Oncology
    Article Open access 12 July 2024
  11. Biliary atresia

    Biliary atresia (BA) is a progressive inflammatory fibrosclerosing disease of the biliary system and a major cause of neonatal cholestasis. It...

    Paul K. H. Tam, Rebecca G. Wells, ... Mark Davenport in Nature Reviews Disease Primers
    Article 11 July 2024
  12. A systematic review on the effectiveness of robot-assisted minimally invasive gastrectomy

    Background

    Robot-assisted minimally invasive gastrectomy (RAMIG) is increasingly used as a surgical approach for gastric cancer. This study assessed...

    L. Triemstra, R. B. den Boer, ... J. P. Ruurda in Gastric Cancer
    Article Open access 11 July 2024
  13. A joint model of longitudinal pharmacokinetic and time-to-event data to study exposure–response relationships: a proof-of-concept study with alectinib

    Purpose

    In exposure–response analyses of oral targeted anticancer agents, longitudinal plasma trough concentrations are often aggregated into a single...

    Lishi Lin, Vincent van der Noort, ... Alwin D. R. Huitema in Cancer Chemotherapy and Pharmacology
    Article Open access 11 July 2024
  14. DCE-MRI to distinguish all monoclonal plasma cell disease stages and correlation with diffusion-weighted MRI/PET-based biomarkers in a hybrid simultaneous whole body-2-[18F]FDG-PET/MRI imaging approach

    Background

    Dynamic contrast-enhanced-MRI (DCE-MRI) is able to study bone marrow angiogenesis in patients with multiple myeloma (MM) and asymptomatic...

    Bastien Jamet, Hatem Necib, ... Francoise Kraeber-Bodere in Cancer Imaging
    Article Open access 11 July 2024
  15. Complete pathological response to pembrolizumab in pretreated pancreatic acinar cell carcinoma

    Background

    Therapeutic approach used for pancreatic ductal adenocarcinoma is usually translated also for the rarer acinar counterpart, which shows a...

    Valeria Merz, Francesca Maines, ... Orazio Caffo in Journal of Cancer Research and Clinical Oncology
    Article Open access 11 July 2024
  16. Survival after thermal ablation versus wedge resection for stage I non-small cell lung cancer < 1 cm and 1 to 2 cm: evidence from the US SEER database

    Background

    This study compared the survival outcomes after thermal ablation versus wedge resection in patients with stage I non-small cell lung cancer...

    Shelly Yim, Wei Chan Lin, ... Ming Hong Yen in Cancer Imaging
    Article Open access 11 July 2024
  17. Anti-TIM3 chimeric antigen receptor-natural killer cells preferentially target primitive acute myeloid leukemia cells with minimal fratricide and exhaustion

    Acute myeloid leukemia (AML) is an aggressive and genetically heterogeneous disease with poor clinical outcomes. Refractory AML is common, and...

    Phatchanat Klaihmon, Parinya Samart, ... Sudjit Luanpitpong in Experimental Hematology & Oncology
    Article Open access 11 July 2024
Did you find what you were looking for? Share feedback.